Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
SHANGHAI and INDIANAPOLIS, May 04, 2020 (GLOBE NEWSWIRE) -- Junshi Biosciences (HKEX: 1877) and Eli Lilly and Company (NYSE: LLY) announced today they have entered into an agreement to co-develop...
-
SHANGHAI, China, April 30, 2020 (GLOBE NEWSWIRE) -- Junshi Biosciences (HKEX: 1877), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and...
-
SHANGHAI, China, March 30, 2020 (GLOBE NEWSWIRE) -- Junshi Biosciences (HKEX: 1877), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and...
-
SHANGHAI, March 30, 2020 (GLOBE NEWSWIRE) -- Junshi Biosciences (HKEX: 1877), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of...
-
SHANGHAI, China, March 30, 2020 (GLOBE NEWSWIRE) -- Junshi Biosciences (HKEX: 1877) today announced that the U.S. Food and Drug Administration (FDA) has recently granted Orphan Drug Designation...
-
SHANGHAI, China, March 20, 2020 (GLOBE NEWSWIRE) -- Junshi Biosciences (HKEX: 1877) announced that it has recently signed a collaboration agreement with the Institute of Microbiology of the Chinese...
-
SHANGHAI, China, March 02, 2020 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd. ("the Company," HKEX: 1877), an innovation-driven biopharmaceutical company dedicated to the discovery and...